TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Is on the Path to Recovery

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) soared 17% on November 7 after the release of strong Q3 results and keeps rising.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Gives Back Controversial New Drug

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) announced this week the sale of the controversial female-libido-enhancing drug Addyi.

    Read more »

    Investing

    Why Canada Goose Holdings Inc.’s Strong Q2 Shouldn’t Convince You to Buy the Stock

    Canada Goose Holdings Inc. (TSX:GOOS)(NYSE:GOOS) had a very strong second quarter, but there are still some concerns investors should have about…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: A High-Risk/High-Reward Stock for Patient Rebound Hunters

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is picking up negative momentum. Should you buy the dip or follow the herd?

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.’s Q3 Results Boosted by Non-Operating Items

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) released its Q3 results today. Results failed to show any sales growth or improved profitability from…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Has Thrown in the Towel: Should You?

    After giving up another revenue-generating asset, investors need to cut ties with Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Shopify Inc. Reports Earnings, Shares Fall, But it’s Only the Beginning

    After failing to meet expectations, the fall of Shopify Inc. (TSX:SHOP)(NYSE:SHOP) may only be starting.

    Read more »

    win
    Dividend Stocks

    4 Oversold Stocks That Could Take Off!

    Barrick Gold Corp. (TSX:ABX)(NYSE:ABX) and these three other stocks have seen big drops in price recently, and it could be a…

    Read more »

    Tech Stocks

    Shopify Inc. Takes Another Left Hook to the Chin

    Shopify Inc. (TSX:SHOP)(NYSE:SHOP) is back in the red following retorts by management. Should investors throw in the towel before another…

    Read more »

    Dividend Stocks

    Where to Invest When Looking Forward to 2018

    Investors wanting to be best positioned going into 2018 will need to carefully consider shares of First National Financial Corp.…

    Read more »

    The Motley Fool
    Investing

    3 Tips That Will Help You Avoid Value Traps

    Value investors are often drawn to companies like Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) for good reason. But be careful to…

    Read more »

    Investing

    What to Do When Short Sellers Attack

    Shopify Inc. (TSX:SHOP)(NYSE:SHOP) has been hit hard by short seller Andrew Left. Here's what investors should do if their stock…

    Read more »